Viewing Study NCT06965361

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:22 PM
Ignite Modification Date: 2026-02-03 @ 8:10 PM
Study NCT ID: NCT06965361
Status: COMPLETED
Last Update Posted: 2025-05-16
First Post: 2025-04-23
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Stromal Tumor-Infiltrating Lymphocyte Levels Are Associated With Immune Checkpoint Proteins In Triple Negative Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
Sponsor: Ziauddin University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Triple Negative Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None carboplatin-based NACT regimen View
None tumor-infiltrating lymphocytes View
None Programmed cell death-1 View
None Programmed cell death Ligand-1 View
None lymphocyte activation gene-3 View
None Triple-negative breast cancer View